| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.14 | 0.3 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.3 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.3 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |